Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Diversified | Small Cap
Health Score : 7.26TTK Healthcare Ltd showcases a mixed financial performance. The company demonstrates strong solvency and financial health, supported by minimal debt and robust earnings per share. Growth metrics are also notable, particularly in asset and net income growth. However, profitability and efficiency present challenges, with low returns on capital employed and high days sales in inventory. Revenue growth is also lagging. While the company maintains adequate liquidity, there is room for improvement in managing current assets and liabilities. Overall, TTK Healthcare exhibits a financially stable profile with potential for enhanced profitability and operational efficiency.
Health Score : 7.26TTK Healthcare Ltd showcases a mixed financial performance. The company demonstrates strong solvency and financial health, supported by minimal debt and robust earnings per share. Growth metrics are also notable, particularly in asset and net income growth. However, profitability and efficiency present challenges, with low returns on capital employed and high days sales in inventory. Revenue growth is also lagging. While the company maintains adequate liquidity, there is room for improvement in managing current assets and liabilities. Overall, TTK Healthcare exhibits a financially stable profile with potential for enhanced profitability and operational efficiency.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
19.84
Industry Median
29.81
Small Cap Median
28.73
P/E RATIO
16.10
P/B RATIO
1.21
Industry Median
4.45
Small Cap Median
4.37
P/S RATIO
N/A
Industry Median
2.73
Small Cap Median
2.61
Others
PEG RATIO
0.38
EV/EBITDA RATIO
11.02
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹930.3 as on Feb 20, 2026.
Growth Score : 5.40The company shows mixed performance in terms of growth. While asset growth and net income growth are strong, revenue growth and EPS growth are weak. Operating profit growth is average. This indicates the company is expanding its asset base and net income, but struggles with revenue and earnings per share growth.
Revenue Growth RatePoorOperating Profit Growth RateAverageEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 25.84 | 21.04 | 3.86 | 6.37 | 6.99 |
| Operating Profit Growth Rate | 15.79 | 40.91 | 19.35 | -5.41 | -25.71 |
| Earnings Per Share (EPS) Growth | -10.47 | 1438.29 | -90.18 | 29.95 | -19.57 |
| Asset Growth Rate | 13.16 | 109.3 | 3.08 | 6.22 | 3.75 |
| Net Income Growth Rate | -8.7 | 1423.81 | -90.16 | 30.16 | -19.51 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | TTKHLTCARE | 7.26 | 16.10 | Neutral | 38.00 | 52.34 | 74.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤22nd Jan 26
Quarterly Financial Results Q3 FY 2025-26
BEARISH SENTIMENT
No Stock News Available at This Moment.
TTK Healthcare Ltd is an Indian diversified company primarily engaged in manufacturing and marketing consumer products, medical devices, and providing printing & publishing services. Part of the TTK Group, the company focuses on various market segments, leveraging a broad product portfolio and established distribution networks across India.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. TTK Healthcare Ltd's P/E ratio (TTM) is 19.84, compared to the industry median of 29.81 and large cap median of 28.73.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. TTK Healthcare Ltd's P/B ratio is 1.21, compared to the industry median of 4.45 and large cap median of 4.37.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. TTK Healthcare Ltd's P/S ratio is 12.87, compared to the industry median of 2.73 and large cap median of 2.61.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. TTK Healthcare Ltd's PEG ratio is 0.38.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. TTK Healthcare Ltd's EV/EBITDA ratio is 11.02.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. TTK Healthcare Ltd's ROE is 5.92%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. TTK Healthcare Ltd's ROA is 1.96%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. TTK Healthcare Ltd's ROCE is 8%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. TTK Healthcare Ltd's operating margin is 3.03%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. TTK Healthcare Ltd's net margin is 7.70%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. TTK Healthcare Ltd's current ratio is 5.88.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. TTK Healthcare Ltd's debt-to-equity ratio is 0.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. TTK Healthcare Ltd's interest coverage ratio is 28.67.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. TTK Healthcare Ltd's DPS is ₹10.23.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. TTK Healthcare Ltd's EPS is -19.57.
(Source line: "Ratios as of 20 Feb 2026, based on last traded price of ₹930.30. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1958 (as TTK Pharma Ltd)
Headquarters: Chennai, Tamil Nadu
Core Offerings: Consumer Products, Medical Devices, Printing & Publishing
Stock Listing: NSE (TTKHLTCARE), BSE (507747)
Promoter: TTK Group
The TTK Group was founded in 1928 by Mr. T. T. Krishnamachari. TTK Healthcare Ltd was incorporated on November 3, 1958, as TTK Pharma Ltd, initially focusing on pharmaceutical products. Over the decades, the company diversified its operations into consumer products, medical devices, and printing & publishing. In 1996, its name was changed to TTK Healthcare Ltd to reflect its broader business portfolio. A significant corporate action in FY22 involved the divestment of its Human Pharma business to focus on its other growth segments.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Consumer Products | Approx 62% | Approx 12.2% margin |
| Medical Devices | Approx 25% | Approx 2.5% margin |
| Printing & Publishing | Approx 13% | Approx 5.2% margin |
Consumer Products: Engaged in the manufacturing and marketing of a diverse range of food products (e.g., Woodward's Gripe Water, Fryums), personal care items, and other household goods, supported by a strong pan-India distribution network.
Medical Devices: Focuses on the development, production, and sale of specialized medical implants and devices, including artificial heart valves, orthopaedic implants, and surgical equipment, serving both domestic and international healthcare sectors.
Printing & Publishing: Provides high-quality printing services and engages in publishing activities, encompassing academic, general interest books, and other printed materials for various clients.
Mr. T. T. Jagannathan (Chairman): A veteran leader, he has been instrumental in guiding the TTK Group's strategic diversification and growth over several decades. Mr. R. Saranyan (Managing Director): Possesses extensive experience within the TTK Group, having held leadership roles across various business verticals, driving operational efficiency and growth.
TTK Protective Devices Limited
TTK Services Private Limited
TTK Pharma Private Limited
TTK British Consumer Products Limited
TTK Biomed Limited
In FY22, the company divested its Human Pharma business for an enterprise value of Rs. 800 crore, streamlining its focus towards consumer products, medical devices, and printing & publishing segments.
The TTK Healthcare Ltd share price today is ₹930.30 on NSE (TTKHLTCARE), as of 09 Sept 2026.
As of 20 Feb 2026, TTK Healthcare Ltd share price is ₹930.30, with previous close ₹930.30. Today's range is ₹930.30 to ₹930.30. The 52-week range is ₹930.30 to ₹930.30.
As of today, TTK Healthcare Ltd's market cap is ₹1,311.72 crore (Small Cap).
TTK Healthcare Ltd's current P/E ratio is 19.84, compared to the General Industrials (Capital Goods) sector average of 32.
TTK Healthcare Ltd's current P/B ratio is 1.21.
TTK Healthcare Ltd's current dividend yield is 1.10%. Last dividend of ₹12.00 per share was declared on 10-Aug-2023.
TTK Healthcare Ltd's EPS (TTM) is ₹-19.57.
TTK Healthcare Ltd is an Indian diversified company primarily engaged in manufacturing and marketing consumer products, medical devices, and providing printing & publishing services. Part of the TTK Group, the company focuses on various market segments, leveraging a broad product portfolio and established distribution networks across India.
TTK Healthcare Ltd is promoted by TTK Group, holding 74.56% as of 20 Feb 2026.
TTK Healthcare Ltd is listed on NSE (TTKHLTCARE) and BSE (507747). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Gross Profit Margin